Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Whitehawk Therapeutics (WHWK) Restructuring Costs (2024)

Historic Restructuring Costs for Whitehawk Therapeutics (WHWK) over the last 1 years, with Q3 2024 value amounting to $2.6 million.

  • Whitehawk Therapeutics' Restructuring Costs changed N/A to $2.6 million in Q3 2024 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year change of. This contributed to the annual value of $2.6 million for FY2024, which is N/A changed from last year.
  • As of Q3 2024, Whitehawk Therapeutics' Restructuring Costs stood at $2.6 million.
  • Whitehawk Therapeutics' 5-year Restructuring Costs high stood at $2.6 million for Q3 2024, and its period low was $2.6 million during Q3 2024.